Rare Disease Clinical Trial Services

Committed to Finding the Cure

When it comes to treating rare diseases, Rho understands that advancements don’t come easy and the rarity of the diseases alone can inhibit the success of clinical trials.

Unfortunately, less than 10% of rare diseases have a specific treatment, most have no cure at all, and many manifest at a young age. Combined with a limited population and lack of disease education and funding, their rare disease isn’t the only thing causing these families to feel alone.

Starting with unique regulatory pathways and continuing through drug development and marketing applications, the differences inherent to rare disease clinical research are ever-present and require a knowledgeable and empathetic CRO with the expertise to design and execute your orphan product development plan.

Our relationships are leading the charge. To better support and aid the development of your product, we’ll lean hard on our strong relationships with advocacy organizations and clinical sites to simplify recruitment and increase retention while meeting regulatory requirements – ultimately providing more feasible rare disease clinical trials.